92 related articles for article (PubMed ID: 8997124)
1. [Cord blood stem cell transplantation for a patient with acute myelogenous leukemia (M1)].
Hattori K; Yabe H; Yabe M; Morimoto T; Iwasaki K; Nakamura Y; Inoguchi S; Tsuji K; Kato S
Rinsho Ketsueki; 1996 Dec; 37(12):1371-6. PubMed ID: 8997124
[TBL] [Abstract][Full Text] [Related]
2. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
[TBL] [Abstract][Full Text] [Related]
3. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery.
Miniero R; Busca A; Roncarolo MG; Saitta M; Iavarone A; Timeus F; Biondi A; Amoroso A; Perugini L; Ciuti E
Bone Marrow Transplant; 1995 Aug; 16(2):229-40. PubMed ID: 7581141
[TBL] [Abstract][Full Text] [Related]
4. Haploidentical related umbilical cord blood stem cell transplant in a child with acute non-lymphocytic leukemia.
Katzenstein HM; Morgan ER; Olsewski M; Danner-Koptik K; Kletzel M
Bone Marrow Transplant; 1997 Apr; 19(8):765-9. PubMed ID: 9134166
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of AML by HLA-compatible sibling umbilical cord blood stem cell transplantation--the first case report in China].
Song Y; Wang G; Wan D
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):399-401. PubMed ID: 11721417
[TBL] [Abstract][Full Text] [Related]
6. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
Sanz GF; Saavedra S; Jiménez C; Senent L; Cervera J; Planelles D; Bolufer P; Larrea L; Martín G; Martínez J; Jarque I; Moscardó F; Plumé G; Andreu R; de la Rubia J; Barragán E; Solves P; Soler MA; Sanz MA
Bone Marrow Transplant; 2001 Apr; 27(7):693-701. PubMed ID: 11360108
[TBL] [Abstract][Full Text] [Related]
7. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide.
Worth L; Tran H; Petropoulos D; Culbert S; Mullen C; Roberts W; Przepiorka D; Chan K
Bone Marrow Transplant; 1999 Nov; 24(9):947-52. PubMed ID: 10556952
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
[TBL] [Abstract][Full Text] [Related]
10. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G
Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995
[TBL] [Abstract][Full Text] [Related]
12. [Umbilical cord blood transplantation for a patient with Diamond-Blackfan syndrome].
Morimoto T; Shikada M; Yabe H; Yabe M; Hattori K; Shimizu T; Inokuchi S; Tsuji K; Iwasaki K; Banba M; Kato S
Rinsho Ketsueki; 1997 Jul; 38(7):610-5. PubMed ID: 9267166
[TBL] [Abstract][Full Text] [Related]
13. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
[TBL] [Abstract][Full Text] [Related]
14. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
Aversa F; Terenzi A; Tabilio A; Falzetti F; Carotti A; Ballanti S; Felicini R; Falcinelli F; Velardi A; Ruggeri L; Aloisi T; Saab JP; Santucci A; Perruccio K; Martelli MP; Mecucci C; Reisner Y; Martelli MF
J Clin Oncol; 2005 May; 23(15):3447-54. PubMed ID: 15753458
[TBL] [Abstract][Full Text] [Related]
15. [Cord blood stem cell transplantation for infantile acute lymphoblastic leukemia after primary cytomegalovirus infection].
Goi K; Sugita K; Miyamoto N; Karakida N; Nakamura M; Kojika S; Iijima K; Kagami K; Nakazawa S
Rinsho Ketsueki; 1997 Nov; 38(11):1229-33. PubMed ID: 9423343
[TBL] [Abstract][Full Text] [Related]
16. Unrelated mismatched cord blood transplantation in an adult with secondary AML.
Lambertengh Deliliers G; Soligo D; Della Volpe A; Bertolini F; Poli F; Romitti L; Tagliaferri E; Ibatici A; Onida F; Annaloro C; Gattinoni L; Sirchia G
Bone Marrow Transplant; 1996 Aug; 18(2):469-72. PubMed ID: 8864467
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
[TBL] [Abstract][Full Text] [Related]
18. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
Howrey RP; Martin PL; Driscoll T; Szabolcs P; Kelly T; Shpall EJ; Bearman SI; Slat-Vasquez V; Rubinstein P; Stevens CE; Kurtzberg J
Bone Marrow Transplant; 2000 Dec; 26(11):1251-4. PubMed ID: 11149743
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
